Tao Capital Partners
Signal active
Investment Firm
Overview
Tao Capital Partners invests in technology, transportation, healthcare, education, and food businesses that have a sustainable positive impact. It is an active investor that supports companies through various stages of their life-cycle.
Tao Capital Partners was founded in 2002 and is based in San Francisco, California.
Highlights
Founded
2002
Industry
Financial Services
Employees
11-50
Investment
92
Lead Investment
14
Exits
18
Stages
Early Stage Venture, Late Stage Venture, Seed
Investor Type
Family Investment Office
Location
United States, North America
Contact Information
Social
Profile Resume
Tao Capital Partners, established in 2002 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Automotive, Manufacturing, Energy Storage, Battery, Financial Services, Venture Capital, Finance, Incubators, FinTech, Enterprise Software. The organization boasts a portfolio of 91 investments, with an average round size of $66.0M and 18 successful exits. Their recent investments include Proterra, DNX Ventures, Greylock, Kleiner Perkins, Mitsui Global Investment. The highest investment round they participated in was $689.8B. Among their most notable exits are Proterra and DNX Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Tao Capital Partners has made 92 investments. Their most recent investment was on Nov 30, 2023, when Elephas raised $55.0M.
Tao Capital Partners has made 16 diversity investments. Their most recent diversity investment was on Jul 17, 2024, when Truvian Sciences raised $74.0M.
investments
92
Diversity investments
16
Lead investments
14
Number of exits
18
Investments
92
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 25, 2023 | - | - | 34.0M |
| Nov 30, 2023 | Elephas | Biotechnology | 55.0M |
| Apr 24, 2024 | Iambic Therapeutics | Software | 50.0M |
| Jul 17, 2024 | Truvian Sciences | Biotechnology | 74.0M |
Exits
18
Funding Timeline
Funding rounds
92
Investors
0
Funds
0
Funding Rounds
92
Tao Capital Partners has raised 92 rounds. Their latest funding was raised on Jul 17, 2024 from a Venture Round - Truvian Sciences round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 25, 2023 | Series C - RapidDeploy | - | 34.0M | - |
| Nov 30, 2023 | Series C - Elephas | - | 55.0M | - |
| Apr 24, 2024 | Series B - Iambic Therapeutics | - | 50.0M | - |
| Jul 17, 2024 | Venture Round - Truvian Sciences | - | 74.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.